Treatment of patients with low-risk myelodysplastic syndromes using a combination of all-trans retinoic acid, interferon alpha, and granulocyte colony-stimulating factor.

W K Hofmann; A Ganser; G Seipelt; O G Ottmann; C Zander; G Geissler; K Hoffmann; K Höffken; J T Fischer; G Isele

doi:10.1007/s002770050488

Treatment of patients with low-risk myelodysplastic syndromes using a combination of all-trans retinoic acid, interferon alpha, and granulocyte colony-stimulating factor.

Identifier:nobleid.org/w1/20260515/EEDF9C9B

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/EEDF9C9B.svg?ark=w1%2F20260515%2FEEDF9C9B)](https://nobleid.org/work/w1/20260515/EEDF9C9B)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work

Treatment of patients with low-risk myelodysplastic syndromes using a combination of all-trans retinoic acid, interferon alpha, and granulocyte colony-stimulating factor.

Identifier:nobleid.org/w1/20260515/EEDF9C9B

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/EEDF9C9B.svg?ark=w1%2F20260515%2FEEDF9C9B)](https://nobleid.org/work/w1/20260515/EEDF9C9B)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work